Adebellizumab
Resectable Lung Non-Small Cell Carcinoma
The First Affiliated Hospital of Guangzhou Medical UniversityPhase 2
—
Rating in progress
Adebellizumab in Resectable Lung Non-Small Cell Carcinoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active